1. Home
  2. CIVB vs CTKB Comparison

CIVB vs CTKB Comparison

Compare CIVB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIVB
  • CTKB
  • Stock Information
  • Founded
  • CIVB 1884
  • CTKB 1990
  • Country
  • CIVB United States
  • CTKB United States
  • Employees
  • CIVB N/A
  • CTKB N/A
  • Industry
  • CIVB Major Banks
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CIVB Finance
  • CTKB Health Care
  • Exchange
  • CIVB Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • CIVB 402.3M
  • CTKB 433.8M
  • IPO Year
  • CIVB N/A
  • CTKB 2021
  • Fundamental
  • Price
  • CIVB $20.45
  • CTKB $3.97
  • Analyst Decision
  • CIVB Buy
  • CTKB Hold
  • Analyst Count
  • CIVB 5
  • CTKB 4
  • Target Price
  • CIVB $25.50
  • CTKB $6.00
  • AVG Volume (30 Days)
  • CIVB 109.4K
  • CTKB 921.5K
  • Earning Date
  • CIVB 10-23-2025
  • CTKB 11-04-2025
  • Dividend Yield
  • CIVB 3.33%
  • CTKB N/A
  • EPS Growth
  • CIVB 18.46
  • CTKB N/A
  • EPS
  • CIVB 2.52
  • CTKB N/A
  • Revenue
  • CIVB $157,428,000.00
  • CTKB $196,035,000.00
  • Revenue This Year
  • CIVB $17.30
  • CTKB N/A
  • Revenue Next Year
  • CIVB $12.90
  • CTKB $7.25
  • P/E Ratio
  • CIVB $8.11
  • CTKB N/A
  • Revenue Growth
  • CIVB 7.00
  • CTKB N/A
  • 52 Week Low
  • CIVB $17.00
  • CTKB $2.37
  • 52 Week High
  • CIVB $25.59
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • CIVB 46.49
  • CTKB 56.62
  • Support Level
  • CIVB $19.87
  • CTKB $3.28
  • Resistance Level
  • CIVB $20.89
  • CTKB $3.95
  • Average True Range (ATR)
  • CIVB 0.45
  • CTKB 0.22
  • MACD
  • CIVB -0.06
  • CTKB 0.01
  • Stochastic Oscillator
  • CIVB 38.67
  • CTKB 77.53

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: